{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:59:57Z","timestamp":1762001997903,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ymgmr.2023.101007","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T01:12:13Z","timestamp":1693962733000},"page":"101007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Induced pluripotent stem cell technology as diagnostic tool in patients with suspected ornithine transcarbamylase deficiency lacking genetic confirmation"],"prefix":"10.1016","volume":"37","author":[{"given":"Adhuresa","family":"Ramosaj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Palak","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Schaller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Laemmle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ymgmr.2023.101007_bb0005","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s10545-015-9839-3","article-title":"The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation","volume":"38","author":"Kolker","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.ymgmr.2023.101007_bb0010","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/jimd.12100","article-title":"Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision","volume":"42","author":"Haberle","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgmr.2023.101007_bb0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jgg.2015.04.003","article-title":"Genotype-phenotype correlations in ornithine Transcarbamylase deficiency: a mutation update","volume":"42","author":"Caldovic","year":"2015","journal-title":"J. Genet. Genom."},{"issue":"9","key":"10.1016\/j.ymgmr.2023.101007_bb0020","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/s10038-019-0614-4","article-title":"Urea cycle disorders-update","volume":"64","author":"Matsumoto","year":"2019","journal-title":"J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.ymgmr.2023.101007_bb0025","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s004310100725","article-title":"Genetic analysis of carbamoylphosphate synthetase I and ornithine transcarbamylase deficiency using fibroblasts","volume":"160","author":"Rapp","year":"2001","journal-title":"Eur. J. Pediatr."},{"issue":"3","key":"10.1016\/j.ymgmr.2023.101007_bb0030","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ymgme.2008.03.009","article-title":"Analysis of mRNA transcripts improves the success rate of molecular genetic testing in OTC deficiency","volume":"94","author":"Engel","year":"2008","journal-title":"Mol. Genet. Metab."},{"issue":"7","key":"10.1016\/j.ymgmr.2023.101007_bb0035","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/humu.20339","article-title":"Mutations and polymorphisms in the human ornithine transcarbamylase (OTC) gene","volume":"27","author":"Yamaguchi","year":"2006","journal-title":"Hum. Mutat."},{"issue":"8","key":"10.1016\/j.ymgmr.2023.101007_bb0040","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/j.transproceed.2015.09.020","article-title":"Liver transplantation for urea cycle disorders: analysis of the united network for organ sharing database","volume":"47","author":"Yu","year":"2015","journal-title":"Transplant. Proc."},{"issue":"1\u20132","key":"10.1016\/j.ymgmr.2023.101007_bb0045","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ymgme.2014.08.001","article-title":"Members of the urea cycle disorders C. A longitudinal study of urea cycle disorders","volume":"113","author":"Batshaw","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgmr.2023.101007_bb0050","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00005792-199811000-00004","article-title":"The phenotype of ostensibly healthy women who are carriers for ornithine transcarbamylase deficiency","volume":"77","author":"Maestri","year":"1998","journal-title":"Medicine."},{"issue":"4","key":"10.1016\/j.ymgmr.2023.101007_bb0055","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/1096-8628(20000814)93:4<313::AID-AJMG11>3.0.CO;2-M","article-title":"Genotype spectrum of ornithine transcarbamylase deficiency: correlation with the clinical and biochemical phenotype","volume":"93","author":"McCullough","year":"2000","journal-title":"Am. J. Med. Genet."},{"issue":"12","key":"10.1016\/j.ymgmr.2023.101007_bb0060","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1056\/NEJM199609193351204","article-title":"Long-term treatment of girls with ornithine transcarbamylase deficiency","volume":"335","author":"Maestri","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ymgmr.2023.101007_bb0065","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/ana.10794","article-title":"Metabolic and neuropsychological phenotype in women heterozygous for ornithine transcarbamylase deficiency","volume":"55","author":"Gyato","year":"2004","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.ymgmr.2023.101007_bb0070","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/hep.32247","article-title":"Aquaporin 9 induction in human iPSC-derived hepatocytes facilitates modeling of ornithine transcarbamylase deficiency","volume":"76","author":"Laemmle","year":"2022","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.ymgmr.2023.101007_bb0075","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nmeth.1591","article-title":"A more efficient method to generate integration-free human iPS cells","volume":"8","author":"Okita","year":"2011","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymgmr.2023.101007_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.667010","article-title":"Integrated isogenic human induced pluripotent stem cell-based liver and heart microphysiological systems predict unsafe drug-drug interaction","volume":"12","author":"Lee-Montiel","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymgmr.2023.101007_bb0085","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s11689-016-9155-8","article-title":"Complexities of X chromosome inactivation status in female human induced pluripotent stem cells-a brief review and scientific update for autism research","volume":"8","author":"Dandulakis","year":"2016","journal-title":"J. Neurodev. Disord."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426923000538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426923000538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:53:38Z","timestamp":1762001618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426923000538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":17,"alternative-id":["S2214426923000538"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2023.101007","relation":{},"ISSN":["2214-4269"],"issn-type":[{"type":"print","value":"2214-4269"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induced pluripotent stem cell technology as diagnostic tool in patients with suspected ornithine transcarbamylase deficiency lacking genetic confirmation","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2023.101007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101007"}}